Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ocular surface tear film and epithelial cell membranes form a dynamic functional unit essential for ocular homeostasis, providing a smooth optical surface and protecting the eye from environmental damage (StatPearls, 2023). The tear film is a complex mixture of lipids, water, and mucins that lubricates the eye and delivers nutrients to the avascular cornea (NIH, 2022). The underlying epithelial cell membranes, particularly the corneal and conjunctival epithelium, are covered by a glycocalyx of membrane-associated mucins like MUC1 and MUC16, which facilitate tear film stability and act as a barrier against pathogens (PubMed, 2021). Dysfunction of this system is the hallmark of Dry Eye Disease (DED), where tear film instability and hyperosmolarity lead to inflammation and damage to the ocular surface (TFOS DEWS II, 2017). Pharmacological treatments include lubricants to supplement the tear film, secretagogues to increase production, and anti-inflammatory agents like cyclosporine or lifitegrast to address the underlying immune response (FDA, 2023).
Drugs targeting this system work through various mechanisms including: lubrication and hydration of the ocular surface; stabilization of the tear film lipid layer to prevent evaporation; inhibition of T-cell mediated inflammation and cytokine release; antagonism of lymphocyte function-associated antigen-1 (LFA-1); and stimulation of the trigeminal parasympathetic pathway to increase natural tear production (StatPearls, 2023; FDA, 2023).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface tear film and epithelial cell membranes.